NF1 c.265_266delinsGG ;(p.T89G)

Variant ID: 17-29486088-AC-GG

NM_001042492.2(NF1):c.265_266delinsGG;(p.T89G)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Dual PI3K/mTOR Inhibitor, XL765, suppresses glioblastoma growth by inducing ER stress-dependent apoptosis.

Oncotargets And Therapy
Zhao, Hang H; Chen, Guangyong G; Liang, Huaxin H
Publication Date: 2019

Variant appearance in text: NF1: T89G
PubMed Link: 31360067
Variant Present in the following documents:
  • ott-12-5415.pdf
View BVdb publication page



Regulation of human glioblastoma cell death by combined treatment of cannabidiol, γ-radiation and small molecule inhibitors of cell signaling pathways.

Oncotarget
Ivanov, Vladimir N VN; Wu, Jinhua J; Hei, Tom K TK
Publication Date: 2017-09-26

Variant appearance in text: NF1: T89G
PubMed Link: 29088769
Variant Present in the following documents:
  • Main text
View BVdb publication page